United States· US:82293-017_21d0ff80-d937-abb3-e063-6394a90af4b7

Sunitinib Malate

A medicinal product containing sunitinib malate, registered in United States by Novugen Pharma (USA) LLC..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSunitinib MalateATC—REGISTER NO.US:82293-017_21d0ff80…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SUNITINIB MALATE
Manufacturer
Novugen Pharma (USA) LLC.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    82293-017-10
  • ndc11
    8229301710
    28 CAPSULE in 1 BOTTLE (82293-017-10)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sunitinib malate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sunitinib malate products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Finland · Sunitinib Avansor
  • Luxembourg · Sunitinib Synthon
  • Malta · Subinit
  • Netherlands · Sunitinib Malate Eugia, Sunitinib Synthon
  • Poland · Sunitinib, Sunitinib Synthon
  • Sweden · Sunitinib Avansor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f57cb9cd-9fc9-4821-9bf7-a08afaa92915
GET /v1/drugs/f57cb9cd-9fc9-4821-9bf7-a08afaa92915?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "SUNITINIB MALATE",
  "productndc": "82293-017",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA218012",
  "marketing_category": "ANDA"
}

See everything about sunitinib malate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.